Company Filing History:
3 out of 905 
1 out of 1,996 
1 out of 21 
Years Active: 2006-2013
Title: Young H Kwon: Innovator in Ocular Drug Delivery and Imaging Technologies
Introduction
Young H Kwon is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of ocular drug delivery and imaging technologies. With a total of 3 patents, his work focuses on innovative solutions for managing eye-related diseases.
Latest Patents
One of his latest patents is titled "Sustained intraocular delivery of drugs from biodegradable polymeric microparticles." This patent describes biodegradable polymeric microparticle compositions that contain active agents useful for treating or preventing diseases of the eye. The microparticles are designed to manage elevated intraocular pressure (IOP) using relatively hydrophilic polymeric materials such as PLGA. The invention emphasizes the use of higher molecular weight polymers to provide a prolonged release of medication over time.
Another significant patent is related to "Methods and systems for optic nerve head segmentation." This method involves classifying the optic nerve cup and rim from a retinal image. It includes receiving a retinal image, determining a feature vector for a candidate pixel, and classifying the pixel as either a cup or rim pixel. The method can utilize stereo pairs of retinal images and can be applied to both color and monochrome images.
Career Highlights
Young H Kwon has worked with esteemed institutions such as the University of Iowa Research Foundation and the State University of New York. His experience in these organizations has allowed him to develop and refine his innovative ideas in ocular health.
Collaborations
Throughout his career, Kwon has collaborated with notable colleagues, including Randy H Kardon and Daniel Tso. These collaborations have contributed to the advancement of his research and inventions.
Conclusion
Young H Kwon is a distinguished inventor whose work in ocular drug delivery and imaging technologies has the potential to significantly impact the field of ophthalmology. His innovative patents reflect his commitment to improving eye health and treatment methodologies.